3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
14
Polycystic Ovary Syndrome
12
Menorrhagia
7
Leiomyoma
7
Prostatic Neoplasms
2
Osteoporosis
2
Neoplasm Metastasis
2
Hyperandrogenism
2
Vaginitis
1
Triple Negative Breast Neoplasms
1
Sexual Dysfunction, Physiological
1
Neoplasms
1
Infertility, Female
1
Hot Flashes
1
Estrogen Receptor Positive Breast Cancer
1
Estrogen Levels Among Breast Cancer Patients
1
Coronary Disease
1
Cardiovascular Diseases
1
Breast Carcinoma In Situ
1
Atrophic Vaginitis
1
Anemia
1
Anatomic Stage III Breast Cancer AJCC v8
1
Abortion, Spontaneous
1
Interventions
pembrolizumab
155
Gemcitabine
139
Capecitabine
121
Paclitaxel
118
Fluorouracil
116
Oxaliplatin
110
Bevacizumab
104
Nivolumab
97
Leucovorin
97
Docetaxel
92
Cisplatin
89
Irinotecan
87
Carboplatin
84
Radiosurgery
83
Cyclophosphamide
70
Cetuximab
70
Magnetic Resonance Spectroscopy
68
Trastuzumab
56
Specimen Handling
56
Biopsy
56
Radiotherapy
55
Ipilimumab
52
Everolimus
48
Pemetrexed
46
Drug Therapy
45
Albumin-Bound Paclitaxel
44
130-nm albumin-bound paclitaxel
43
Doxorubicin
41
Fulvestrant
38
aldesleukin
37
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasm Metastasis
×
Estradiol
×
Clear all
NCT05716516
2026-05-05
ESTHER
Dartmouth-Hitchcock Medical Center
Phase 2
Recruiting
36 enrolled
NCT05900895
2025-11-20
PHOEBE
Dartmouth-Hitchcock Medical Center
Phase 1
Recruiting
6 enrolled